The multifaceted roles of mesenchymal stem cell-derived exosomes in digestive system malignancies: mechanisms and therapeutic implications

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

• Level A · Stronger Clinical Evidence
• Level B · Emerging clinical evidence with positive signals
• Level C · Early human research exploring benefits
• Level D · Scientific groundwork from lab and animal studies
• Emerging · Emerging topic under active research

Abstract (original English)

Mesenchymal stem cell-derived exosomes (MSC-Exos) have emerged as key mediators of intercellular communication within the tumor microenvironment. However, a comprehensive synthesis of their paradoxical roles in digestive system tumors remains absent. This review provides an in-depth analysis of the molecular mechanisms by which MSC-Exos regulate tumor progression, with a focus on how they transfer specific non-coding RNAs and proteins to target cells, thereby modulating angiogenesis, epithelial-mesenchymal transition, immune evasion, and drug resistance. We highlight the functional heterogeneity of MSC-Exos in colorectal, liver, gastric, and pancreatic cancers, and examine how signals from the tumor microenvironment remodel their molecular cargo, establishing complex feedback loops. Furthermore, we discuss emerging translational frontiers, including the engineering of MSC-Exos as targeted drug delivery vehicles. By integrating mechanistic insights with clinical challenges, this review aims to elucidate the complex biology of MSC-Exos and pave new avenues for their application in precision oncology for digestive system tumors.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.